Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 53, 2018 - Issue 6
Submit an article Journal homepage
265
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment?

Kwang Min KimDepartment of Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, South Korea;
,
Jiyu KimDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;
,
Dong Hyun SinnDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; Correspondence[email protected]
,
Hye Seung KimStatistics and Data Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, South Korea
,
Kyunga KimStatistics and Data Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, South Korea
,
Wonseok KangDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;
,
Geum-Youn GwakDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;
,
Yong-Han PaikDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;
,
Moon Seok ChoiDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;
,
Joon Hyeok LeeDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;
,
Kwang Cheol KohDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;
&
Seung Woon PaikDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;
show all
Pages 727-733 | Received 27 Jan 2018, Accepted 24 Mar 2018, Published online: 03 Apr 2018

References

  • Jung KW, Won YJ, Oh CM, et al. Prediction of cancer incidence and mortality in Korea, 2017. Cancer Res Treat. 2017;49:306–312.
  • Bertuccio P, Turati F, Carioli G, et al. Global trends and predictions in hepatocellular carcinoma mortality. J Hepatol. 2017;67:302–309.
  • Kang SH, Yim HJ, Kim SY, et al. Proton pump inhibitor therapy is associated with reduction of early bleeding risk after prophylactic endoscopic variceal band ligation: a retrospective cohort study. Medicine. 2016;95:e2903.
  • Yu SJ. A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016. Clin Mol Hepatol. 2016;22:7–17.
  • Bruix J, Sherman M. American Association for the Study of Liver D. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–1022.
  • European Association for the Study of the Liver, European Organisation for Research, Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–943.
  • Korean Liver Cancer Study Group, National Cancer Center Korea. 2014 KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma. Gut Liver.2015;9:267–317.
  • Braillon A. Hepatocellular carcinoma. Lancet. 2012;380:469.
  • Lederle FA, Pocha C. Screening for liver cancer: the rush to judgment. Ann Intern Med. 2012;156:387–389.
  • Wong LL, Reyes RJ, Kwee SA, et al. Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world? Clin Mol Hepatol. 2017;23:239–248.
  • Meissner HI, Smith RA, Rimer BK, et al. Promoting cancer screening: learning from experience. Cancer. 2004;101:1107–1117.
  • Amit S, Jorge AM. Screening for hepatocellular carcinoma. Gastroenterol Hepatol.2008;4:201–208.
  • Korean Liver Cancer Study Group, National Cancer Center Korea. Practice guidelines for management of hepatocellular carcinoma 2009. Korean J Hepatol. 2009;15:391–423.
  • Cucchetti A, Trevisani F, Pecorelli A, et al. Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma. J Hepatol. 2014;61:333–341.
  • Mourad A, Deuffic-Burban S, Ganne-Carrie N, et al. Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approach. Hepatology. 2014;59:1471–1481.
  • Thein HH, Campitelli MA, Yeung LT, et al. Improved survival in patients with viral hepatitis-induced hepatocellular carcinoma undergoing recommended abdominal ultrasound surveillance in Ontario: a population-based retrospective cohort study. PLoS One. 2015;10:e0138907.
  • Singal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med. 2014;11:e1001624.
  • Wu CY, Hsu YC, Ho HJ, et al. Association between ultrasonography screening and mortality in patients with hepatocellular carcinoma: a nationwide cohort study. Gut. 2016;65:693–701.
  • Poustchi H, Farrell GC, Strasser SI, et al. Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed? Hepatology. 2011;54:1998–2004.
  • Brenner H, Altenhofen L, Katalinic A, et al. Sojourn time of preclinical colorectal cancer by sex and age: estimates from the German national screening colonoscopy database. Am J Epidemiol. 2011;174:1140–1146.
  • Duffy SW, Nagtegaal ID, Wallis M, et al. Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival. Am J Epidemiol. 2008;168:98–104.
  • Sarkar M, Stewart S, Yu A, et al. Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans. J Viral Hepat. 2012;19:594–600.
  • Wong LL, Limm WM, Severino R, et al. Improved survival with screening for hepatocellular carcinoma. Liver Transpl. 2000;6:320–325.
  • Chang CF, Su WJ, Chou TY, et al. Hepatocellular carcinoma with Pancoast’s syndrome as an initial symptom: a case report. Jpn J Clin Oncol. 2001;31:119–121.
  • Guo X, Yin J, Jiang Y. Solitary skull metastasis as the first symptom of hepatocellular carcinoma: case report and literature review. Neuropsychiatr Dis Treat. 2014;10:681–686.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.